MeSH tree: D04.210.500.745.745.654.829.395.400
A UC San Francisco-led study has for the first time identified genetic variants that predict whether patients will respond to treatment for preterm birth, a condition that affects one in 10 infants born in the United States.
Jan 23, 2024
0
39
A new research perspective was published in Oncotarget, titled "Deciphering the mechanisms of action of progesterone in breast cancer."
Jul 10, 2023
0
57
The U.S. Food and Drug Administration on Thursday formally withdrew its approval of a drug that was meant to prevent preterm births.
Apr 7, 2023
0
60
Pregnant women will no longer have any drug to prevent preterm birth after the maker of the only available treatment announced Tuesday that it will withdraw its product, Makena, from the market.
Mar 8, 2023
0
25
Federal health advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.
Oct 19, 2022
0
15
The maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort this week to keep its medication on the market, even as health regulators insist that it doesn't work.
Oct 17, 2022
0
48
